SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending sharply lower after announcing that Marvell canceled all purchase orders inherited from its acquisition of Celestial AI due to an alleged breach of confidentiality. Investors and community members are expressing significant frustration over management's handling of the disclosure, leading to widespread speculation about the company's future contracts and immediate valuation.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors as they await topline Phase 3 data from the HAELO trial, which the community sees as a potential validation for their in vivo CRISPR platform. Traders are actively debating the high short interest and the stock's susceptibility to a squeeze, with many weighing the clinical promise of a functional HAE cure against the broader volatility affecting the biotech sector.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as investors weigh strong AI and automotive growth potential against near-term headwinds like supply chain constraints and cautious analyst sentiment. The stock is a primary focus for the community, which remains divided on whether the current price represents a buying opportunity or a deeper structural decline.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is experiencing significant bullish momentum driven by heavy short interest and mounting anticipation for its acquisition of Northern Data, which effectively expands its cloud and GPU infrastructure. The community is actively discussing a potential short squeeze, citing record-high short interest and strong backing from strategic partner Tether as catalysts for a potential rally.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing significant market movement driven by speculative interest in its shift toward custom AI chip design and high-performance server CPUs. Community discussions are split between euphoria over its long-term potential as an AI infrastructure backbone and intense debate regarding its valuation, with many traders actively debating the merits of aggressive shorting versus holding for a potential parabolic breakout.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as it approaches a high-profile oral presentation of pancreatic cancer data at Digestive Disease Week, which the community views as a critical catalyst for the stock. Traders are actively accumulating shares, citing strong scientific momentum and the company's progress in expanding global clinical trials.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares is experiencing massive volatility and bullish momentum driven by a strong semiconductor sector rally, fueled by earnings optimism and ongoing AI infrastructure spending. Investors are actively debating whether the current parabolic price action signifies a sustainable super-cycle or a speculative bubble, leading to intense sentiment clashes between bullish 'diamond hands' and traders betting on a sharp mean reversion.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is currently seeing significant investor attention driven by positive Phase 3 acne data and the potential for its FASN inhibitor denifanstat as a cornerstone MASH treatment. The community is actively debating the company's valuation, the strategic shift toward combination therapies, and the high probability of a future buyout given the surge in M&A activity within the metabolic disease sector.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The Direxion Daily Semiconductor Bear 3X Shares (SOXS) is seeing intense volatility and record-breaking volume as traders debate whether the semiconductor sector's prolonged winning streak represents an unsustainable AI bubble or a resilient super-cycle. Community sentiment remains deeply polarized between aggressive short-sellers betting on a mean reversion and bulls who argue that relentless momentum and capital rotation into chip-related infrastructure make shorting the sector a high-risk trade.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is generating significant investor buzz as it makes its market debut, with the community highlighting its strategic backing from major players like Amazon and Dow to address the surging energy demands of AI data centers. Traders are actively debating the company's valuation and long-term potential compared to other modular nuclear reactor peers, fueled by high initial demand and its positioning as a key player in the clean energy infrastructure space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Real Brokerage To Acquire RE/MAX, LLC For Around $880 Mln To Create Real REMAX Group

(RTTNews) - The Real Brokerage Inc. (REAX), a technology-powered real estate brokerage, and RE/MAX Holdings, Inc. (RMAX), a real estate franchisor on Monday announced that they have entered into a...

Shareholder Alert: Ademi LLP investigates whether RE/MAX Holdings, Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether RE/MAX Holdings, Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether RE/MAX Holdings, Inc. is...

RMAX Stock Alert: Halper Sadeh LLC is Investigating Whether RE/MAX Holdings, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of RE/MAX Holdings, Inc. (NYSE: RMAX) to The Real Brokerage Inc. for either 5.152 shares of the combined company or $13.80 in...

<ul class="summary-bullets"><li>RE/MAX shareholders can choose to receive either 5.152 shares of the new company or $13.80 in cash per share, representing a roughly 72% premium over the stock’s closing price on Friday.</li><li>The Real Brokerage’s current CEO, Tamir Poleg, will serve as chairman and CEO of the combined company, which will be named Real REMAX Group.</li><li>After closing, Real shareholders are expected to own about 59% of the business.</li></ul>Shares of RE/MAX Holdings (RMAX) jumped more than 20% in pre-market trading on Monday after The Real Brokerage (REAX) announced the acquisition of the company at an enterprise value of around $880 million.If the pre-market levels hold after the opening bell, <a href="https://stocktwits.com/symbol/RMAX">RMAX shares</a> would trade at their highest levels in nearly seven months. Meanwhile, <a href="https://stocktwits.com/symbol/RMAX">REAX stock</a> was down around 3%.<h2 class="st-heading-2">Real Brokerage To Own 59% Of Combined Firm</h2>Under the agreement, RE/MAX shareholders can choose to receive either 5.152 shares of the new company or $13.80 in cash per share, representing a roughly 72% premium over the stock’s closing price on Friday.After closing, Real shareholders are expected to own about 59% of the business. The deal, slated to close in the second half of 2026, is backed by financing from Morgan Stanley and Apollo Global Management.The Real Brokerage’s current CEO, Tamir Poleg, will serve as chairman and CEO of the combined company, which will be named Real REMAX Group.<h2 class="st-heading-2">Boost For Real’s Margins</h2>The combined company would have generated about $2.3 billion in annual revenue and $157 million in adjusted earnings on a pro forma basis in 2025, the company said. The deal is also expected to boost Real’s earnings and margins in the first full year after closing.The merger also brings together Real’s AI-powered brokerage model with RE/MAX’s well-established global franchise network spanning more than 120 countries and including over 145,000 agents. Both the RE/MAX and Motto Mortgage brands will continue to operate, alongside Real’s existing brokerage platform.“Together, we will create a more innovative, more productive and more connected real estate ecosystem that we believe will generate substantial long-term value for agents, franchisees, consumers and shareholders,” Poleg said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for RMAX on Stocktwits remained in the ‘extremely bullish’ territory over the past 24 hours, amid ‘extremely high’ message volumes.One user expects RMAX shares to more than double in value from current levels.<stembedurl>https://stocktwits.com/MidusS2/message/651481268</stembedurl>Another user simply said the deal makes “so much sense.”<stembedurl>https://stocktwits.com/GTMStox/message/651481761</stembedurl>The deal reflects a broader consolidation trend across the real estate industry, as firms combine to scale operations, improve technology, and attract more agents and clients in an increasingly competitive market.In March 2025, Rocket Companies (RKT) acquired Redfin, followed by Compass (COMP) striking a deal to buy Anywhere Real Estate in September. Larger brokerages can invest more in technology and offer more in-house listings, making it easier to attract agents, buyers, and sellers.RMAX shares have gained 4.5% so far this year, while REAX stock fell around 28%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/cmpx-stock-retail-buzzing-ahead-of-cancer-drug-trial-update/cZBNZa7Re2t">This Small-Cap Biotech Is Gearing Up For A Make-Or-Break Cancer Drug Data Drop</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Kraken Robotics on Tuesday announced that it has entered into an agreement to acquire Covelya Group Limited.(Image Courtesy: Getty Images)

Why Did RMAX Stock Surge 20% In Pre-Market Today?

The Real Brokerage announced the acquisition of RE/MAX Holdings at an enterprise value of around $880 million.

Equity

Real to Acquire REMAX, Creating a Leading Technology-Enabled Global Real Estate Platform

The Real Brokerage Inc. (NASDAQ: REAX) (Real), a leading technology-powered real estate brokerage, and RE/MAX Holdings, Inc. (NYSE: RMAX) (RE/MAX Holdings), the parent company of RE/MAX, LLC (REMAX...

RE/MAX (RMAX) Projected to Post Quarterly Earnings on Thursday

RE/MAX (NYSE:RMAX) will be releasing its Q1 2026 earnings after the market closes on Thursday, April 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-30-remax-holdings-inc-stock...

RE/MAX HOLDINGS, INC. TO RELEASE FIRST QUARTER 2026 RESULTS ON MAY 7, 2026

RE/MAX HOLDINGS, INC. TO RELEASE FIRST QUARTER 2026 RESULTS ON MAY 7, 2026 RE/MAX HOLDINGS, INC. TO RELEASE FIRST QUARTER 2026 RESULTS ON MAY 7, 2026 PR Newswire DENVER, April 22, 2026 DENVER, April...

REMAX MARCH 2026 NATIONAL HOUSING REPORT SHOWS SPRING SALES PICKING UP

REMAX MARCH 2026 NATIONAL HOUSING REPORT SHOWS SPRING SALES PICKING UP REMAX MARCH 2026 NATIONAL HOUSING REPORT SHOWS SPRING SALES PICKING UP PR Newswire DENVER, April 20, 2026 March Home Sales Surge...

Should Value Investors Buy REMAX (RMAX) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

REMAX Agents are Most Productive for 18 Years Straight

REMAX Agents are Most Productive for 18 Years Straight REMAX Agents are Most Productive for 18 Years Straight PR Newswire DENVER, April 15, 2026 RealTrends Verified data confirms REMAX agents close...

RE/MAX Holdings Inc - Ordinary Shares - Class A

Proxy filing

RE/MAX Holdings, Inc. engages in the provision of real estate franchise services through its subsidiaries. It operates through the following segments: Real Estate, Mortgage and Marketing Funds. The Real Estate segment consists of the company’s owned and independent global franchising operations under the RE/MAX brand name and technology and data subscription for Gadberry and the First app. The Mortgage segment consists of the firm's mortgage brokerage franchising operations under the Motto Mortgage brand name and mortgage loan processing services and licensed software under the wemlo brand. The Marketing Funds segment is involved in marketing campaigns designed to build and maintain brand awareness and the development and operation of agent marketing technology. The company was founded by David L. Liniger and Gail A. Liniger in 1973 and is headquartered in Denver, CO.

Earnings

Fed / Macro data

Headlines / Geopolitics

Other (drop a comment)

What will be the main driver of the market this week?

Stocktwits

Stocktwits Polls

Traders are debating the $13.80 per share acquisition terms, with some questioning the discount and others concerned about proration risks.

Investors are actively questioning why the stock is trading significantly below the $13.80 buyout price offered by the acquiring tech platform.

The stock has seen massive relative volume, surging over 20% on speculation and early confirmation of the merger agreement.

Market sentiment remains sharply divided as skeptics dismiss the price action as a pump-and-dump while bulls hold for higher valuation.

RMAX
RE/MAX Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RMAX News

RMAXRE/MAX Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RMAX News

RMAX
RE/MAX Holdings Inc - Ordinary Shares - Class A